November 18, 2015
Webinar
This August, in Carnegie Mellon University v. Marvell Technology Group, the Federal Circuit vacated a portion of the largest damages judgment in history ─ for $1.54 billion ─ instructing the district court to determine whether the accused products had been “sold” in the United States. Even though the products at issue were made and used abroad, U.S. sales activity could potentially still support damages. As this decision illustrates, global supply chains can greatly impact the enforcement of U.S. patents.
In this webinar, we will discuss the reach of U.S. patents in today’s global economy and provide practical patenting and enforcement strategies for manufacturing companies. Specifically, we will address:
Jennifer H. Roscetti
Jeffrey C. Totten
1:00 - 2:00 p.m. EDT
Conference
19th Annual Forum on Pharma & Biotech Patent Litigation in Europe
May 19-20, 2026
Amsterdam
Panel Discussion
May 5, 2026
London
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.